ScholarIQanswers from OpenAlex

Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages

PaperCitations, authors & open-access status

Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages have?

ScholarIQcitation count

Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages has 414 citations in the OpenAlex counts ScholarIQ stores.

When was Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages published?

ScholarIQyear

Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages has 2020 year in the ScholarIQ index.

What is the open-access status of Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages?

ScholarIQoa status

Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages has green oa status in the ScholarIQ index.

What is the DOI of Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages?

ScholarIQdoi

The DOI for Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages is on the source record.

What is the PMID of Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages?

ScholarIQpmid

The PMID for Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages is on the source record.

What is the OpenAlex record for Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages?

ScholarIQopenalex

The OpenAlex for Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial